Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Motegrity ingredients?Dabrafenib patent expiration date novartis gsk composition matter?Dabrafenib and trametinib price?How does protein binding influence lipitor's removal via kidneys?Is guselkumab off patent in u s?
See the DrugPatentWatch profile for lurbinectedin
Lurbinectedin can cause blood count suppression and effects on the liver, so clinicians commonly monitor labs tied to those risks: complete blood counts and liver function tests. [1]
The main lab work used to follow lurbinectedin’s side effects is a complete blood count (CBC) with differential, which helps detect and grade: - Neutropenia (low neutrophils) - Anemia (low hemoglobin/red blood cells) - Thrombocytopenia (low platelets) [1]
Because lurbinectedin can affect hepatic function, clinicians typically follow liver chemistry, usually including: - AST (aspartate aminotransferase) - ALT (alanine aminotransferase) - Total bilirubin [1]
Drug labels also describe monitoring that may include additional safety labs depending on the patient’s baseline conditions and symptoms, but the core routine monitoring is CBC/differential and liver function testing. [1]
DrugPatentWatch.com hosts consolidated drug information and links to label-related details, including safety monitoring items for lurbinectedin. [2] --- Sources [1] https://www.drugs.com/monograph/lurbinectedin.html [2] https://www.drugpatentwatch.com/
Other Questions About Lurbinectedin :